These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3972756)

  • 1. Determination of the activity on Legionella of eight macrolides and related agents by comparative testing on three media.
    Bornstein N; Roudier C; Fleurette J
    J Antimicrob Chemother; 1985 Jan; 15(1):17-22. PubMed ID: 3972756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Practical problems raised by antibiotic minimal inhibitory concentration determination in Legionella species (author's transl)].
    Bornstein N; Roudier C; Fleurette J
    Pathol Biol (Paris); 1982 Jun; 30(6):421-5. PubMed ID: 6810285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of the Etest to antimicrobial susceptibility testing of Legionella spp.
    Rhomberg PR; Bale MJ; Jones RN
    Diagn Microbiol Infect Dis; 1994 Jul; 19(3):175-8. PubMed ID: 7820999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of charcoal- and starch-based media for testing susceptibilities of Legionella species to macrolides, azalides, and fluoroquinolones.
    Pendland SL; Martin SJ; Chen C; Schreckenberger PC; Danziger LH
    J Clin Microbiol; 1997 Nov; 35(11):3004-6. PubMed ID: 9350781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance of Mycoplasma pneumoniae to macrolide and analogous antibiotics.
    Suzaki K
    Sci Rep Res Inst Tohoku Univ Med; 1979 Dec; 26(3-4):71-91. PubMed ID: 121168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The in-vitro activity of moxifloxacin against Legionella species and the effects of medium on susceptibility test results.
    Ruckdeschel G; Dalhoff A
    J Antimicrob Chemother; 1999 May; 43 Suppl B():25-9. PubMed ID: 10382872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro antibiotic susceptibility of Legionellaceae: search for alternative antimicrobial drugs.
    Traub WH; Spohr M
    Chemotherapy; 1984; 30(3):182-7. PubMed ID: 6734305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of Legionella spp. to mycinamicin I and II and other macrolide antibiotics: effects of media composition and origin of organisms.
    Edelstein PH; Pasiecznik KA; Yasui VK; Meyer RD
    Antimicrob Agents Chemother; 1982 Jul; 22(1):90-3. PubMed ID: 7125633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vitro comparison of macrolides, lincosamides and synergistins on Neisseria gonorrhoeae.
    Thabaut A; Meyran M; Huerre M
    J Antimicrob Chemother; 1985 Jul; 16 Suppl A():213-5. PubMed ID: 3932306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of Legionella species to antimicrobial agents.
    Chen SC; Paul ML; Gilbert GL
    Pathology; 1993 Apr; 25(2):180-3. PubMed ID: 8367199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disk diffusion antimicrobial susceptibility testing of members of the family Legionellaceae including erythromycin-resistant variants of Legionella micdadei.
    Dowling JN; McDevitt DA; Pasculle AW
    J Clin Microbiol; 1984 Jun; 19(6):723-9. PubMed ID: 6565706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility of Legionella pneumophila to eight antimicrobial agents including four macrolides under different assay conditions.
    Liebers DM; Baltch AL; Smith RP; Hammer MC; Conroy JV
    J Antimicrob Chemother; 1989 Jan; 23(1):37-41. PubMed ID: 2526110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of Pittsburgh pneumonia agent (Legionella micdadei) and other newly recognized members of the genus Legionella to nineteen antimicrobial agents.
    Pasculle AW; Dowling JN; Weyant RS; Sniffen JM; Cordes LG; Gorman GM; Feeley JC
    Antimicrob Agents Chemother; 1981 Dec; 20(6):793-9. PubMed ID: 7325645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of lomefloxacin (NY-198 or SC 47111), ciprofloxacin, and erythromycin against 100 clinical Legionella strains.
    Edelstein PH; Gaudet EA; Edelstein MA
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):93S-95S. PubMed ID: 2791505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro synergy testing of macrolide-quinolone combinations against 41 clinical isolates of Legionella.
    Martin SJ; Pendland SL; Chen C; Schreckenberger P; Danziger LH
    Antimicrob Agents Chemother; 1996 Jun; 40(6):1419-21. PubMed ID: 8726012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative susceptibility of Legionella pneumophila and Legionella longbeachae to 12 antimicrobial agents.
    Nimmo GR; Bull JZ
    J Antimicrob Chemother; 1995 Jul; 36(1):219-23. PubMed ID: 8537269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of Legionella pneumophila to twenty antimicrobial agents.
    Edelstein PH; Meyer RD
    Antimicrob Agents Chemother; 1980 Sep; 18(3):403-8. PubMed ID: 7425611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WIN 57273 is bactericidal for Legionella pneumophila grown in alveolar macrophages.
    Edelstein PH; Edelstein MA
    Antimicrob Agents Chemother; 1989 Dec; 33(12):2132-6. PubMed ID: 2619277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of binding parameters of macrolides, lincosamides, and streptogramins to Legionella pneumophila.
    Fournet MP; Zini R; Deforges L; Duval J; Tillement JP
    J Pharm Sci; 1987 Feb; 76(2):153-6. PubMed ID: 3572754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility of Legionella spp. to imipenem and 27 other beta-lactam antibiotics.
    Ruckdeschel G; Ehret W; Ahl A
    Eur J Clin Microbiol; 1984 Oct; 3(5):463-7. PubMed ID: 6594234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.